Niihara Yutaka
- SEC CIK
- 0001517691
No open-market purchases or sales filed in the past year.
Current role at each company
- EMMA Emmaus Life Sciences, Inc.Chairman and CEOas of Jan 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Niihara Yutaka as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2022 (view filing)2:50 PM ET | Oct 31-Nov 2 | 3 daysLate | Niihara YutakaChairman and CEO | PPurchaseCommon stock, $0.001 par value | +27.5K | $0.4355 | +$12.0K | +0.2%12.0M after | 3 lots |
| Dec 1, 2022 (view filing)1:35 PM ET | Nov 3-30 | 28 daysLate | Niihara YutakaChairman and CEO | PPurchaseCommon stock, $0.001 par value | +52.6K | $0.4035 | +$21.2K | +0.4%12.0M after | 5 lots |